Subscribe to RSS
DOI: 10.1055/s-0042-1748903
Multisystem Inflammatory Syndrome in Children Associated with COVID-19 Infection: A Comprehensive Review
Funding None![](https://www.thieme-connect.de/media/10.1055-s-00029029/EFirst/lookinside/thumbnails/10-1055-s-0042-1748903_2100123-1.jpg)
Abstract
The Multisystem Inflammatory Syndrome in Children (MIS-C) is a postinfectious syndrome associated with coronavirus disease 2019 (COVID-19) disease in children. The aim of this study is to conduct a thorough review to assist health care professionals in diagnosis and management of this complication of COVID-19 disease in children. A thorough systematic review was conducted through an on-line search based on MIS-C with the primary focus on epidemiology, clinical characteristics, diagnosis, pathophysiology, management, and long-term follow-up. This syndrome is characterized by an exaggerated and uncontrolled release of proinflammatory cytokines involving dysfunction of both innate and adaptive immunity. In this review, a summary of observational studies and case reports was conducted, in which we found that MIS-C generates multiple-organ failure frequently presenting with hemodynamic instability further characterized by Kawasaki-like symptoms (such as persistent high fever, polymorphic rash, and bilateral conjunctivitis) and predominance of gastrointestinal and cardiovascular signs and symptoms. Keys to effective management involve early diagnosis, timely treatment and re-evaluation following hospital discharge. Diagnosis is marked by significant elevation of inflammatory biomarkers, laboratory evidence of COVID-19 infection or history of recent exposure, and absence of any other plausible explanation for the associated signs, symptoms, and presentation. Management includes hemodynamic stabilization, empiric antibiotic therapy (de-escalation if cultures and polymerase chain reaction studies indicate no bacterial co-infection), immunomodulatory therapy (methylprednisolone, intravenous immunoglobulin, anakinra, tocilizumab, siltuximab, Janus kinase inhibitors, tumor necrosis factor-α inhibitors), antivirals (remdesivir), and anticoagulation (acetylsalicylic acid, unfractionated or low-molecular-weight heparin or new oral anticoagulants). In addition, we identified poor prognostic risk factors to include concurrent comorbidities, blood-component consumption and marrow suppression (lymphopenia, thrombocytopenia), depletion of homeostatic components (hypoalbuminemia), and marked evidence of a hyperinflammatory response to include elevated values of ferritin, C-reactive protein, and D-dimer. MIS-C constitutes a postinfectious syndrome characterized by a marked cytokine storm, characterized by fever, bilateral conjunctivitis, and multiple organ dysfunction. Promoting future research and long-term follow-up will be essential for the development of guidelines and recommendations leading to effective identification and management of MIS-C.
Publication History
Received: 16 November 2021
Accepted: 21 March 2022
Article published online:
27 June 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 WHO, Coronavirus disease (COVID-19) update. World Health Organization [serial online]. Accessed November 10, 2021 at: https://covid19.who.int
- 2 Jones VG, Mills M, Suarez D. et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 2020; 10 (06) 537-540
- 3 AEP, Información para familias. Asociación española de pediatría [serial online]. 2020 :1–2. Accessed November 10, 2021 at: http://www.teleton.org/home/contenido/informacion-para-familias-hito
- 4 Daskalakis DC. 2020 Health Alert # 13: Pediatric multi-system inflammatory syndrome potentially associated with COVID-19. NYC health [serial online]. 2020 ;(4):1–2. Accessed November 10, 2021 at: https://www1.nyc.gov/assets/doh/downloads/pdf/han/alert/2020/covid-19-pediatric-multi-system-inflammatory-syndrome.pdf
- 5 CDC. Health department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the United States. Covid data tracker. CDC [serial online]. Accessed November 10, 2021 at: https://covid.cdc.gov/covid-data-tracker/#mis-national-surveillance
- 6 WHO. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. World Health Organization [serial online]. Accessed November 10, 2021 at: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19
- 7 Centers for Disease Control and Prevention. Multisystem inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). Atlanta. GA: Centers for Disease Control and Prevention;
- 8 Royal College of Paediatrics and Child Health. Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19. London: Royal College of Paediatrics and Child Health [serial online]. Accessed November 10, 2021 at: https://www.rcpch.ac.uk/resources/guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19
- 9 Agency KDC. Case definition of coronavirus-disease- 2019-associated multisystem inflammatory syndrome in children. Cheongju (Korea): Korea Disease Control Agency [serial online]. Accessed November 10, 2021 at: http://ncov.mohw.go.kr/upload/140/202010/1601875824179_20201005143024.pdf
- 10 Giraldo-Alzate C, Tamayo-Múnera C, López-Barón E, Caicedo-Baez MC, Piñeres-Olave BE. Síndrome inflamatorio multisistémico en niños asociado a COVID-19. Revisión narrativa de la literatura a propósito de un caso. Acta Colomb Cuidado Intens. 2020 ;226:45-54e1 DOI: 10.1016/j.acci.2020.11.002
- 11 Dufort EM, Koumans EH, Chow EJ. et al; New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team. Multisystem inflammatory syndrome in children in New York State. N Engl J Med 2020; 383 (04) 347-358
- 12 Davies P, Evans C, Kanthimathinathan HK. et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health 2020; 4 (09) 669-677
- 13 Feldstein LR, Rose EB, Horwitz SM. et al; Overcoming COVID-19 Investigators, CDC COVID-19 Response Team. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020; 383 (04) 334-346
- 14 Payne AB, Gilani Z, Godfred-Cato S. et al; MIS-C Incidence Authorship Group. Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2. JAMA Netw Open 2021; 4 (06) e2116420
- 15 Suksatan W, Chupradit S, Yumashev AV. et al. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. Int Immunopharmacol 2021; 101 (Pt B): 108217
- 16 Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel) 2020; 7 (07) 2-14
- 17 Consiglio CR, Cotugno N, Sardh F. et al; CACTUS Study Team. The Immunology of multisystem inflammatory syndrome in children with COVID-19. Cell 2020; 183 (04) 968.e7-981.e7
- 18 Haigh K, Syrimi ZJ, Irvine S. et al. Hyperinflammation with COVID-19: the key to patient deterioration?. Clin Infect Pract 2020; 7: 100033
- 19 Henderson LA, Yeung RSM. MIS-C: early lessons from immune profiling. Nat Rev Rheumatol 2021; 17 (02) 75-76
- 20 Lee PY, Platt CD, Weeks S. et al. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1. J Allergy Clin Immunol 2020; 146 (05) 1194-1200.e1
- 21 Brodsky NN, Ramaswamy A, Lucas CL. The mystery of MIS-C Post-SARS-CoV-2 infection. Trends Microbiol 2020; 28 (12) 956-958
- 22 Rafferty MS, Burrows H, Joseph JP, Leveille J, Nihtianova S, Amirian ES. Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: current knowledge and implications for public health. J Infect Public Health 2021; 14 (04) 484-494
- 23 Waseem M, Shariff MA, Tay ET. et al. Multisystem inflammatory syndrome in children. J Emerg Med 2021; 6: 50-53
- 24 Buonsenso D, Riitano F, Valentini P. Pediatric inflammatory multisystem syndrome temporally related with SARS-CoV-2: immunological similarities with acute rheumatic fever and toxic shock syndrome. Front Pediatr 2020; 8 (06) 574
- 25 Waltuch T, Gill P, Zinns LE. et al. Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department. Am J Emerg Med 2020; 38 (10) 2246.e3-2246.e6
- 26 Chou J, Platt CD, Habiballah S. et al; Taking on COVID-19 Together Study Investigators. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). J Allergy Clin Immunol 2021; 148 (03) 732.e1-738.e1
- 27 Giannattasio A, Maglione M, Zenzeri L. et al. A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID-19 infection: a novel management for a new disease?. J Med Virol 2021; 93 (01) 112-114
- 28 Beckmann ND, Comella PH, Cheng E. et al. Cytotoxic lymphocytes are dysregulated in multisystem inflammatory syndrome in children. Medrxiv. 2020; 08 (09) 2899
- 29 Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395 (10229): 1033-1034
- 30 DeBiasi RL, Harahsheh AS, Srinivasalu H. et al; Children's National Hospital MIS-C Taskforce. Multisystem inflammatory syndrome of children: subphenotypes, risk factors, biomarkers, cytokine profiles, and viral sequencing. J Pediatr 2021; 237: 125-135.e18
- 31 Frenkel LD, Gomez F, Bellanti JA. COVID-19 in children: pathogenesis and current status. Allergy Asthma Proc 2021; 42 (01) 8-15
- 32 Gruber CN, Patel RS, Trachtman R. et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell 2020; 183 (04) 982.e14-995.e14
- 33 Vella LA, Giles JR, Baxter AE. et al; UPenn COVID Processing Unit. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci Immunol 2021; 6 (57) 1-19
- 34 Zhu YP, Shamie I, Lee JC. et al; Pediatric Emergency Medicine Kawasaki Disease Research Group Consortium. Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C. J Clin Invest 2021; 131 (20) e147076
- 35 Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 2020; 20 (06) 355-362
- 36 Theoharides TC, Conti P. COVID-19 and multisystem inflammatory syndrome, or is it mast cell activation syndrome?. J Biol Regul Homeost Agents 2020; 34 (05) 1633-1636
- 37 Rostad CA, Chahroudi A, Mantus G. et al. Quantitative SARS-CoV-2 serology in children with multisystem inflammatory syndrome (MIS-C). Pediatrics 2020; 146 (06) e2020018242
- 38 Bulut O, Kilic G, Netea MG, Netea MG. SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19. Ann Med 2020; 22 (04) 1-14
- 39 Weisberg SP, Connors TJ, Zhu Y. et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol 2021; 22 (01) 25-31
- 40 Gruber CN, Patel RS, Trachtman R. et al. Mapping Systemic Inflammation And Antibody Responses In Multisystem Inflammatory Syndrome In Children (MIS-C). Cell 2020; 183 (04) 982-995.e14
- 41 Castagnoli R, Votto M, Licari A. et al. Severe Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: A systematic review. JAMA Pediatr 2020; 174 (09) 882-889
- 42 Whittaker E, Bamford A, Kenny J. et al; PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; 324 (03) 259-269
- 43 Hester N, Pozos G, Kalaskar P, Koutsari B. Clinical Mis-C: Clinic-Diagnostic / Dispo Recs for Suspected Multisystem Inflammatory Mis-C. Children Minnesota. 2021; 25 (01) 01-09
- 44 Ghodsi A, Mahmoudabadi E, Ghahremani S, Malek A. Cardiac manifestations of multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection. Arch Pediatr Infect Dis. 2021; 9 (04) e109915
- 45 Nepal G, Shrestha GS, Rehrig JH. et al. Neurological manifestations of COVID-19 associated multi-system inflammatory syndrome in children: a systematic review and meta-analysis. J Nepal Health Res Counc 2021; 19 (01) 10-18
- 46 Swann OV, Holden KA, Turtle L. et al; ISARIC4C Investigators. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ 2020; 370: m3249
- 47 Jackson RJ, Chavarria HD, Hacking SM. A case of multisystem inflammatory syndrome in children mimicking acute appendicitis in a COVID-19 pandemic area. Cureus 2020; 12 (09) e10722
- 48 Yozgat CY, Uzuner S, Bursal Duramaz B. et al. Dermatological manifestation of pediatrics multisystem inflammatory syndrome associated with COVID-19 in a 3-year-old girl. Dermatol Ther (Heidelb) 2020; 33 (04) e13770
- 49 Klocperk A, Parackova Z, Dissou J. et al. Case report: systemic inflammatory response and fast recovery in a pediatric patient with COVID-19. Front Immunol 2020; 11 (07) 1665
- 50 Cogan E, Foulon P, Cappeliez O, Dolle N, Vanfraechem G, De Backer D. Multisystem inflammatory syndrome with complete Kawasaki disease features associated with SARS-CoV-2 infection in a young adult. a case report. Front Med (Lausanne) 2020; 7 (04) 428
- 51 Cazzaniga M, Baselli LA, Cimaz R, Guez SS, Pinzani R, Dellepiane RM. SARS-COV-2 infection and Kawasaki disease: case report of a hitherto unrecognized association. Front Pediatr 2020; 8 (07) 398
- 52 Regev T, Antebi M, Eytan D. et al. Pediatric inflammatory multisystem syndrome with central nervous system involvement and hypocomplementemia following SARS-COV-2 infection. Pediatr Infect Dis J 2020; 39 (08) e206-e207
- 53 Greene AG, Saleh M, Roseman E, Sinert R. Toxic shock-like syndrome and COVID-19: multisystem inflammatory syndrome in children (MIS-C). Am J Emerg Med 2020; 38 (11) 2492.e5-2492.e6
- 54 Velasco Puyó P, Moreno L, Díaz de Heredia C, Rivière JG, Soler Palacín P. Tocilizumab in a child with acute lymphoblastic leukemia and COVID-19-related cytokine release syndrome. An Pediatr (Barc) 2020; 93 (02) 132-133
- 55 Vari D, Miller JM, Rellosa N, Srivastava S, Frizzola M, Thacker D. Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: retrospective diagnosis of a puzzling presentation. A case report. Prog Pediatr Cardiol 2020; 58 (June): 101270
- 56 Abdel-Mannan O, Eyre M, Löbel U. et al. Neurologic and radiographic findings associated with COVID-19 infection in children. JAMA Neurol 2020; 77 (11) 1440-1445
- 57 Ng KF, Kothari T, Bandi S. et al. COVID-19 multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection. J Med Virol 2020; 92 (11) 2880-2886
- 58 Bahrami A, Vafapour M, Moazzami B, Rezaei N. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran. J Paediatr Child Health 2021; 57 (06) 922-925
- 59 Chiotos K, Bassiri H, Bajerens E. et al. Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic: a case series. J Pediatric Infect Dis Soc 2020; 9 (03) 393-398
- 60 Chiu JS, Lahoud-Rahme M, Schaffer D, Cohen A, Samuels-Kalow M. Kawasaki disease features and myocarditis in a patient with COVID-19. Pediatr Cardiol 2020; 41 (07) 1526-1528
- 61 Schupper AJ, Yaeger KA, Morgenstern PF. Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19. Childs Nerv Syst 2020; 36 (08) 1579-1580
- 62 Dallan C, Romano F, Siebert J, Politi S, Lacroix L, Sahyoun C. Septic shock presentation in adolescents with COVID-19. Lancet Child Adolesc Health 2020; 4 (07) e21-e23
- 63 Raut S, Roychowdhoury S, Bhakta S, Sarkar M, Nandi M. Incomplete Kawasaki disease as presentation of COVID-19 infection in an infant: a case report. J Trop Pediatr 2021; 67 (03) 1-4
- 64 Gupta A, Gill A, Sharma M, Garg M. Multi-system inflammatory syndrome in a child mimicking Kawasaki disease. J Trop Pediatr 2021; 67 (03) 1-5
- 65 Naguib MN, Raymond JK, Vidmar AP. New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19. J Pediatr Endocrinol Metab 2020; 34 (01) 147-150
- 66 Lee PY, Day-Lewis M, Henderson LA. et al. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest 2020; 130 (11) 5942-5950
- 67 Alkan G, Sert A, Oz SKT, Emiroglu M, Yılmaz R. Clinical features and outcome of MIS-C patients: an experience from Central Anatolia. Clin Rheumatol 2021; 40 (10) 4179-4189
- 68 Reiff DD, Mannion ML, Samuy N, Scalici P, Cron RQ. Distinguishing active pediatric COVID-19 pneumonia from MIS-C. Pediatr Rheumatol Online J 2021; 19 (01) 21
- 69 Diorio C, Henrickson SE, Vella LA. et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest 2020; 130 (11) 5967-5975
- 70 Torres JP, Izquierdo G, Acuña M. et al. Multisystem inflammatory syndrome in children (MIS-C): report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic. Int J Infect Dis 2020; 100: 75-81
- 71 Capone CA, Misra N, Ganigara M. et al. Six month follow-up of patients with multi-system inflammatory syndrome in children. Pediatrics 2021; 148 (04) 509-510
- 72 Mamishi S, Movahedi Z, Mohammadi M. et al. Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran. Epidemiol Infect 2020; 148: 196
- 73 Pouletty M, Borocco C, Ouldali N. et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis 2020; 79 (08) 999-1006
- 74 Grimaud M, Starck J, Levy M. et al. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care 2020; 10 (01) 69
- 75 Miller J, Cantor A, Zachariah P, Ahn D, Martinez M, Margolis KG. Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children that is related to coronavirus disease 2019: a single center experience of 44 cases. Gastroenterology 2020; 159 (04) 1571-1574.e2
- 76 Kaushik S, Aydin SI, Derespina KR. et al. multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C): a multi-institutional study from New York City. J Pediatr 2020; 224: 24-29
- 77 Cheung EW, Zachariah P, Gorelik M. et al. Multisystem inflammatory syndrome related to covid-19 in previously healthy children and adolescents in New York City. JAMA 2020; 324 (03) 294-296
- 78 Feldstein LR, Rose EB, Horwitz SM. et al; Overcoming COVID-19 Investigators, CDC COVID-19 Response Team. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020; 383 (04) 334-346
- 79 Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020; 395 (10237): 1067-1068
- 80 UpToDate. Covid-19 multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis. UpToDate [serial online]. Accessed November 6, 2021 at: https://www.uptodate.com/contents/covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-clinical-features-evaluation-anddiagnosis?search=MIS-.Cdiagnosis&source=search_result&selectedTitle=1∼95&usage_type=default&display_rank=1#H2797860347
- 81 Deza Leon MP, Redzepi A, McGrath E. et al. Covid-19-associated pediatric multisystem inflammatory syndrome. J Pediatric Infect Dis Soc 2020; 9 (03) 407-408
- 82 Verdoni L, Mazza A, Gervasoni A. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395 (10239): 1771-1778
- 83 Hameed S, Elbally H, Reid C, Santos R. et al. Spectrum of imaging findings on chest radiographs, US, CT, and MRI images in multisystem inflammatory syndrome in children associated with COVID-19. Radiology 2021; 298 (01) E1-E10
- 84 Vergnano S, Alders N, Armstrong C. et al. Severe refractory Kawasaki disease in seven infants in the COVID-19 era. Lancet Rheumatol. 2020; 2 (09) e520
- 85 Evans C, Davies P. SARS-CoV-2 pediatric inflammatory syndrome. Ann Oncol 2020; 31 (03) 110-115
- 86 Khaund Borkotoky R, Banerjee Barua P, Paul SP, Heaton PA. COVID-19-related potential multisystem inflammatory syndrome in childhood in a neonate presenting as persistent pulmonary hypertension of the newborn. Pediatr Infect Dis J 2021; 40 (04) e162-e164
- 87 Yasuhara J, Watanabe K, Takagi H, Sumitomo N, Kuno T. COVID-19 and multisystem inflammatory syndrome in children: a systematic review and meta-analysis. Pediatr Pulmonol 2021; 56 (05) 837-848
- 88 Capone CA, Subramony A, Sweberg T. et al; Northwell Health COVID-19 Research Consortium. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory syndrome of childhood associated with severe acute respiratory syndrome coronavirus 2 Infection. J Pediatr 2020; 224: 141-145
- 89 Ramcharan T, Nolan O, Lai CY. et al. Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr Cardiol 2020; 41 (07) 1391-1401
- 90 Blumfield E, Levin TL, Kurian J, Lee EY, Liszewski MC. Imaging findings in multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease (COVID-19). AJR Am J Roentgenol 2021; 216 (02) 507-517
- 91 Calcaterra V, Biganzoli G, Dilillo D. et al. Non-thyroidal illness syndrome and SARS-CoV-2-associated multisystem inflammatory syndrome in children. J Endocrinol Invest 2022; 45 (01) 199-208
- 92 Dove ML, Jaggi P, Kelleman M. et al. Multisystem inflammatory syndrome in children: survey of protocols for early hospital evaluation and management. J Pediatr 2021; 229: 33-40
- 93 Mariani R, Liu H. Severe transient pancytopenia with dyserythropoiesis and dysmegakaryopoiesis in COVID-19-associated MIS-C. Blood 2020; 136 (25) 2964
- 94 Verdugo P, Álvarez P, Aroca P. et al. Parámetros hematológicos y biomarcadores predictores de gravedad en Síndrome Inflamatorio Pediátrico Multisistémico asociado a SARS-CoV-2. Andes Pediatr 2021; 92 (03) 382-388
- 95 Domínguez-Rodríguez S, Villaverde S, Sanz-Santaeufemia FJ. et al; EPICO-AEP Working Group. A Bayesian model to predict COVID-19 severity in children. Pediatr Infect Dis J 2021; 40 (08) e287-e293
- 96 Fernandes DM, Oliveira CR, Guerguis S. et al. Severe acute respiratory syndrome coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth. J Pediatr 2021; 230 (03) 23.e10-31.e10
- 97 Zhao Y, Yin L, Patel J, Tang L, Huang Y. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis. J Med Virol 2021; 93 (07) 4358-4369
- 98 Abrams JY, Oster ME, Godfred-Cato SE. et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health 2021; 5 (05) 323-331
- 99 Brisca G, Consolaro A, Caorsi R. et al. Timely recognition and early multi-step antinflammatory therapy may prevent ICU admission of patients with MIS-C: proposal for a severity score. Front Pediatr 2021; 9 (02) 783745
- 100 Jonat B, Gorelik M, Boneparth A. et al. Multisystem inflammatory syndrome in children associated with coronavirus disease 2019 in a children's hospital in New York City: patient characteristics and an institutional protocol for evaluation, management, and follow-up. Pediatr Crit Care Med 2021; 22 (03) e178-e191
- 101 Henderson LA, Canna SW, Friedman KG. et al. American College of Rheumatology Clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol 2021; 73 (04) e13-e29
- 102 Takia L, Angurana SK, Nallasamy K, Bansal A, Muralidharan J. Updated management protocol for multisystem inflammatory syndrome in children (MIS-C). J Trop Pediatr 2021; 67 (03) 1-13
- 103 de Castro REV, Medeiros DNM, Prata-Barbosa A, de Magalhães-Barbosa MC. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med 2020; 21 (10) 924-925
- 104 Yancy CW, Jessup M, Bozkurt B. et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128 (16) 1810-1852
- 105 Multisystem Inflammatory Syndrome ACP. in Children (MIS-C) Interim Guidance. American academic of Pediatrics. ACP [serial online]. Accessed November 10, 2021 at: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance/
- 106 Mohta A, Mehta RD, Ghiya BC. Multisystem inflammatory syndrome in children related to COVID-19 with urticarial vasculitis - a double whammy!. Indian Pediatr 2021; 58 (09) 894-895
- 107 García-Salido A, Antón J, Martínez-Pajares JD. et al. Documento español de consenso sobre diagnóstico, estabilización y tratamiento del síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2 (SIM-PedS). An Pediatr (Barc) 2021; 94 (02) 116.e1-116.e11
- 108 Jiang L, Tang K, Levin M. et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis 2020; 20 (11) e276-e288